or
forgot password

    • cancer clinical trials in kansas city, MO

    • Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia
    Kansas City VA Medical Center
    Kansas City, Missouri 64128
    Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myelogenous Leukemia (AML)
    Accuracy of FDG-PET Scanning to Diagnose Malignant Thyroid Nodules
    VAMC
    Kansas City, Missouri
    Thyroid Neoplasms
    S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
    Heartland Hematology Oncology Associates, Incorporated

    Trial Locations
    Heartland Hematology Oncology Associates, Incorporated
    North Kansas City Hospital
    Saint Luke's Cancer Institute at Saint Luke's Hospital
    Research Medical Center
    Parvin Radiation Oncology
    Leukemia
    Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
    St. Joseph Medical Center

    Trial Locations
    St. Joseph Medical Center
    Heartland Hematology Oncology Associates, Incorporated
    North Kansas City Hospital
    Saint Luke's Cancer Institute at Saint Luke's Hospital
    Research Medical Center
    Parvin Radiation Oncology
    Lung Cancer
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Research Medical Center

    Trial Locations
    Research Medical Center
    Saint Luke's Cancer Institute
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Kansas City Cancer Centers - South
    Kansas City, Missouri 64131
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
    Truman Medical Center

    Trial Locations
    Truman Medical Center
    Kansas City Cancer Centers - North
    Kansas City Cancer Center - South
    Neuroendocrine Carcinoma
    The Study of Barrett's Esophagus: What Are the Factors of Progression
    Department of Veterans Affairs Medical Center
    Kansas City, Missouri 64128
    Barrett's Esophagus, Esophageal Neoplasms
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    North Kansas City Hospital

    Trial Locations
    North Kansas City Hospital
    Research Medical Center
    Saint Luke's Cancer Institute
    Saint Luke's Hospital of Kansas City
    Saint Joseph Health Center
    Liberty Radiation Oncology Clinic
    Truman Medical Center
    Heartland Hematology and Oncology Associates Incorporated
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Truman Medical Center
    Kansas City, Missouri 64108
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
    CCOP - Kansas City
    Kansas City, Missouri 64131
    Musculoskeletal Complications, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    North Kansas City Hospital

    Trial Locations
    North Kansas City Hospital
    Research Medical Center
    Saint Luke's Hospital of Kansas City
    Saint Joseph Health Center
    Liberty Radiation Oncology Clinic
    Truman Medical Center
    Heartland Hematology and Oncology Associates Incorporated
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer
    Truman Medical Center - Hospital Hill

    Trial Locations
    Truman Medical Center - Hospital Hill
    St. Joseph Medical Center
    North Kansas City Hospital
    Saint Luke's Cancer Institute at Saint Luke's Hospital
    Research Medical Center
    Parvin Radiation Oncology
    Colorectal Cancer
    Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
    Research Medical Center

    Trial Locations
    Research Medical Center
    Saint Luke's Cancer Institute
    Saint Luke's Hospital of Kansas City
    Saint Joseph Health Center
    Liberty Radiation Oncology Clinic
    Truman Medical Center
    Heartland Hematology and Oncology Associates Incorporated
    Stage IV Pancreatic Cancer
    Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
    Heartland Hematology Oncology Associates, Incorporated

    Trial Locations
    Heartland Hematology Oncology Associates, Incorporated
    North Kansas City Hospital
    Saint Luke's Cancer Institute at Saint Luke's Hospital
    Research Medical Center
    Lung Cancer
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Research Medical Center
    Kansas City, Missouri 64132
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma